BioRexis Pharmaceutical Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
BioRexis Pharmaceutical General Information
Description
Producer of bio pharmaceuticals. The company offers protein and peptide drugs with pharmacology and Trans-bodies to replace conventional monoclonal antibodies.
Contact Information
Website
www.biorexis.comCorporate Office
- 3400 Horizon Drive
- King of Prussia, PA 19406
- United States
Corporate Office
- 3400 Horizon Drive
- King of Prussia, PA 19406
- United States
BioRexis Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Feb-2007 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Mar-2004 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 06-Jan-2003 | $8M | $8M | Completed | Product Development |
BioRexis Pharmaceutical Patents
BioRexis Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2007331195-A1 | Transferrin fusion protein libraries | Inactive | 12-Dec-2006 | ||
| CA-2673085-A1 | Transferrin fusion protein libraries | Active | 12-Dec-2006 | ||
| CA-2673085-C | Transferrin fusion protein libraries | Inactive | 12-Dec-2006 | ||
| EP-2114999-A2 | Transferrin fusion protein libraries | Pending | 12-Dec-2006 | ||
| EP-2479189-A1 | Transferrin fusion protein libraries | Active | 12-Dec-2006 | C07K14/705 |
BioRexis Pharmaceutical Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anthem Capital Management | Venture Capital | Minority | ||
| Gund Investment | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Prism Venture Management | Venture Capital | Minority | ||
| ProQuest Investments | Venture Capital | Minority |
BioRexis Pharmaceutical FAQs
-
When was BioRexis Pharmaceutical founded?
BioRexis Pharmaceutical was founded in 2002.
-
Where is BioRexis Pharmaceutical headquartered?
BioRexis Pharmaceutical is headquartered in King of Prussia, PA.
-
What industry is BioRexis Pharmaceutical in?
BioRexis Pharmaceutical’s primary industry is Drug Discovery.
-
Is BioRexis Pharmaceutical a private or public company?
BioRexis Pharmaceutical is a Private company.
-
What is BioRexis Pharmaceutical’s current revenue?
The current revenue for BioRexis Pharmaceutical is .
-
How much funding has BioRexis Pharmaceutical raised over time?
BioRexis Pharmaceutical has raised $38M.
-
Who are BioRexis Pharmaceutical’s investors?
Anthem Capital Management, Gund Investment, Johnson & Johnson JJDC, Prism Venture Management, and ProQuest Investments are 5 of 7 investors who have invested in BioRexis Pharmaceutical.
-
When was BioRexis Pharmaceutical acquired?
BioRexis Pharmaceutical was acquired on 01-Feb-2007.
-
Who acquired BioRexis Pharmaceutical?
BioRexis Pharmaceutical was acquired by Pfizer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process